More Business Wire
View Older Stories View Newer Stories-
EIC Subsidiary PAL Aerospace Appoints Simon Carroll as President, PAL Aerospace
-
Faraday Future to Participate in Cantor’s 2nd Annual Global Technology & Industrial Growth Conference in New York City on March 10-11, 2026
-
Menē Clients Now Hold Over CAD$350 Million in Pure Gold and Platinum Jewelry
-
Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering
-
ShipStation® Improves Fulfilment Efficiency for Businesses in Australia and New Zealand With Enhanced Platform Capabilities
-
Operio Group Named Distributor for Schaefer Technologies in the United Kingdom and European Union
-
KBRA Assigns Preliminary Ratings to RCKT Mortgage Trust 2026-CES3 (RCKT 2026-CES3)
-
Independence Realty Trust Declares First Quarter 2026 Dividend
-
EquipmentShare Announces Fourth Quarter and Full Year 2025 Financial Results Conference Call
-
Joby to Begin U.S. Operations in 2026 Under White House Air Taxi Program
-
MaxLinear, Inc. Announces Upcoming Financial Conference Participation
-
Investors Title Company Declares Quarterly Dividend
-
Arcus Biosciences Announces New Employment Inducement Grants
-
Casey's Announces Third Quarter Results
-
Teriyaki Madness Taps Toast to Fuel Next Growth Phase
-
UiPath Achieves AIUC-1 Certification, Setting New Standard for AI Agent Security and Reliability
-
NRC Health Announces Board Authorization of $60 Million Share Repurchase Program
-
Franklin Street Properties Corp. Announces Fourth Quarter and Full Year 2025 Results
-
Centauri Debuts Best in KLAS® SES Notify and Next-Gen Clinical Data Solutions at HIMSS26
-
Voyager Reports Fourth Quarter and Full Year 2025 Financial Results, Enters 2026 with Record Backlog, Increases 2026 Revenue Guidance
-
Ellington Credit Declares Monthly Common Dividend
-
Ellington Financial Declares Common and Preferred Dividends
-
DemandFactor Rebrands as Demand.com, Signaling a Bold New Chapter in B2B Demand Generation
-
COPT Defense to Present at J.P. Morgan’s 2026 Industrials Conference
-
W. R. Berkley Corporation Names Ryan Miller President of Berkley Southeast
-
Net Power Reports Fourth Quarter and Year End 2025 Results and Provides Business Update
-
York Space Systems to Release Fourth Quarter and Full Year 2025 Results on March 19, 2026
-
Vicarious Surgical Reports Fourth Quarter and Full Year 2025 Financial Results
-
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2025 Results on March 12, 2026
-
Williams’ Transco Commences Registered Exchange Offer for Its 5.100% Senior Notes Due 2036 and 5.750% Senior Notes Due 2056
-
DWS Municipal Income Trust Declares Monthly Distribution
-
Essential Properties Realty Trust, Inc. Announces Quarterly Dividend of $0.31 per Share for the First Quarter of 2026
-
OPAL Fuels Announces Closing of $180 Million Preferred Stock Facility
-
DNP Select Income Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
Duff & Phelps Utility and Infrastructure Fund Inc. Discloses Sources of Distribution – Section 19(a) Notice
-
United Natural Foods to Participate at the UBS Global Consumer and Retail Conference
-
Myomo Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
-
REPAY Reports Fourth Quarter and Full Year 2025 Financial Results
-
Parents Say the Village is Vanishing — New Research Confirms
-
HPE Reports Fiscal 2026 First Quarter Results
-
Shift4 Announces Executive Promotions and Leadership Changes
-
Myomo and Elevance Health Agree to Contract for Multi-State Network Participation
-
Yext Announces Fourth Quarter and Fiscal Year 2026 Results
-
Transcat Appoints Jaime Irick as President and Chief Executive Officer
-
Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyop
-
Nu Skin Appoints Chayce Clark as COO
-
Wisk and Texas Selected by White House to Lead the Safe Introduction of Autonomous Air Taxi Flight
-
Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy
-
Definium Therapeutics Announces New Employee Inducement Grants
-
Primaris REIT Announces Distribution for March 2026

